Cargando…

TP53 mutation prevalence in normal airway epithelium as a biomarker for lung cancer risk

BACKGROUND: There is a need for biomarkers that improve accuracy compared with current demographic risk indices to detect individuals at the highest lung cancer risk. Improved risk determination will enable more effective lung cancer screening and better stratification of lung nodules into high or l...

Descripción completa

Detalles Bibliográficos
Autores principales:	Craig, Daniel J., Crawford, Erin L., Chen, Heidi, Grogan, Eric L., Deppen, Steven A., Morrison, Thomas, Antic, Sanja L., Massion, Pierre P., Willey, James C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10464352/ https://www.ncbi.nlm.nih.gov/pubmed/37612638 http://dx.doi.org/10.1186/s12885-023-11266-7

Ejemplares similares

Technical advance in targeted NGS analysis enables identification of lung cancer risk-associated low frequency TP53, PIK3CA, and BRAF mutations in airway epithelial cells
por: Craig, Daniel J., et al.
Publicado: (2019)

Tumoral Densities of T-Cells and Mast Cells Are Associated With Recurrence in Early-Stage Lung Adenocarcinoma
por: Kammer, Michael N., et al.
Publicado: (2023)

(68)Ga-DOTATATE PET/CT imaging of indeterminate pulmonary nodules and lung cancer
por: Walker, Ronald, et al.
Publicado: (2017)

Mitigating the Risk of t-MNs Development: TP53 or Not TP53?
por: Tesio, Melania
Publicado: (2023)

The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis
por: Leroy, Bernard, et al.
Publicado: (2013)

Normal and Functional TP53 in Genetically Stable Myxoid/Round Cell Liposarcoma
por: Ståhlberg, Anders, et al.
Publicado: (2014)

(18)F-FSPG PET imaging for the evaluation of indeterminate pulmonary nodules
por: Paez, Rafael, et al.
Publicado: (2022)

p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas.
por: Walker, C., et al.
Publicado: (1994)

Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients
por: Langerød, A, et al.
Publicado: (2000)

Orthogonal arrays in normal and injured respiratory airway epithelium
Publicado: (1985)

The TP53 fertility network
por: Paskulin, Diego d’Avila, et al.
Publicado: (2012)

Mortality for Robotic- vs Video-Assisted Lobectomy–Treated Stage I Non-Small Cell Lung Cancer Patients
por: Cui, Yong, et al.
Publicado: (2020)

Creation and preliminary characterization of a Tp53 knockout rat
por: McCoy, Aaron, et al.
Publicado: (2013)

TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
por: Wang, Haiwei, et al.
Publicado: (2022)

The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes
por: McGraw, K L, et al.
Publicado: (2015)

TP53 modulates radiotherapy fraction size sensitivity in normal and malignant cells
por: Anbalagan, Selvakumar, et al.
Publicado: (2021)

TP53 isoform junction reads based analysis in malignant and normal contexts
por: Vural, Suleyman, et al.
Publicado: (2021)

Optimisation of TP53 reporters by systematic dissection of synthetic TP53 response elements
por: Trauernicht, Max, et al.
Publicado: (2023)

Reply to Zhao et al.: Integrated Biomarkers for Indeterminate Pulmonary Nodules: Is 2-Year Imaging Follow-Up Enough for Suspected Benign Lesions?
por: Kammer, Michael N., et al.
Publicado: (2022)

p53 Immunohistochemistry Patterns Are Surrogate Biomarkers for TP53 Mutations in Gastrointestinal Neuroendocrine Neoplasms
por: Li, Junjie, et al.
Publicado: (2021)

TP53 mutation status: emerging biomarker for precision radiation medicine?
por: Willers, Henning, et al.
Publicado: (2018)

TP53: an oncogene in disguise
por: Soussi, T, et al.
Publicado: (2015)

TP53 in Myelodysplastic Syndromes
por: Jiang, Yan, et al.
Publicado: (2021)

Cancer-associated fibroblasts in early-stage lung adenocarcinoma correlate with tumor aggressiveness
por: Vasiukov, Georgii, et al.
Publicado: (2023)

Expression signature based on TP53 target genes doesn't predict response to TP53-MDM2 inhibitor in wild type TP53 tumors
por: Sonkin, Dmitriy
Publicado: (2015)

Prognostic significance of TP53 alterations in breast carcinoma.
por: Andersen, T. I., et al.
Publicado: (1993)

Expression of TP53 Isoforms p53β or p53γ Enhances Chemosensitivity in TP53(null) Cell Lines
por: Silden, Elisabeth, et al.
Publicado: (2013)

Immunolocalization of NLRP3 Inflammasome in Normal Murine Airway Epithelium and Changes following Induction of Ovalbumin-Induced Airway Inflammation
por: Tran, Hai B., et al.
Publicado: (2012)

Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53
por: Abrams, Stephen L., et al.
Publicado: (2022)

Engineering Airway Epithelium
por: Soleas, John P., et al.
Publicado: (2012)

Apoptosis and the Airway Epithelium
por: White, Steven R.
Publicado: (2011)

Redox-sensitive TP53INP1 SUMOylation as an oxidative stress sensor to activate TP53
por: Bonacci, Thomas, et al.
Publicado: (2014)

TP53 Combined Phenotype Score Is Associated with the Clinical Outcome of TP53-Mutated Myelodysplastic Syndromes
por: Yabe, Mariko, et al.
Publicado: (2021)

TP53_PROF: a machine learning model to predict impact of missense mutations in TP53
por: Ben-Cohen, Gil, et al.
Publicado: (2022)

Intronic TP53 Polymorphisms Are Associated with Increased Δ133TP53 Transcript, Immune Infiltration and Cancer Risk
por: Eiholzer, Ramona A., et al.
Publicado: (2020)

Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma
por: Sun, Hao, et al.
Publicado: (2020)

Specific TP53 Mutants Overrepresented in Ovarian Cancer Impact CNV, TP53 Activity, Responses to Nutlin-3a, and Cell Survival()
por: Mullany, Lisa K., et al.
Publicado: (2015)

Interactions of oxygen radicals with airway epithelium.
por: Wright, D T, et al.
Publicado: (1994)

TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with TP53 Mutation/Deletion
por: Eisenmann, Eric D., et al.
Publicado: (2022)

Prognosis, Biology, and Targeting of TP53 Dysregulation in Multiple Myeloma
por: Flynt, Erin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cebvoivli35urmfhue8grivg6v